Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bertrand

Showing results (581-590 of 606) with videos related to

Pageof 61
Sort By:
Plos Genetics|March 3, 2017
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's diseaseFiona Kerr, Oyinkan Sofola-Adesakin, Dobril K Ivanov, et al.
Oncotarget|June 11, 2015
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastomaClaudia C Faria, Sameer Agnihotri, Stephen C Mack, et al.
Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.
Bulletin Du Cancer|January 26, 1999
[Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers]L Gautié, P Canal, A Menguy, et al.
JCO Precision Oncology|October 15, 2021
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an <i>NTRK2</i> Fusion: The Impact of Integrated Genomic ProfilingRoss Mangum, Jacquelyn Reuther, Kelsey C Bertrand, et al.
Nature|July 31, 2024
Histone serotonylation regulates ependymoma tumorigenesisHsiao-Chi Chen, Peihao He, Malcolm McDonald, et al.
Acta Neuropathologica Communications|September 3, 2024
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangementJulieann C Lee, Selene C Koo, Larissa V Furtado, et al.
Neuro-Oncology|May 29, 2023
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter studyAndrew M Donson, Kelsey C Bertrand, Kent A Riemondy, et al.
The Journal of Experimental Medicine|May 20, 2025
Correction: Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastomaStephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
The Journal of Experimental Medicine|April 6, 2019
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastomaStephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
Pageof 61

Showing results (581-590 of 606) with videos related to

Sort By:
Pageof 61
Plos Genetics|March 3, 2017
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's diseaseFiona Kerr, Oyinkan Sofola-Adesakin, Dobril K Ivanov, et al.
Oncotarget|June 11, 2015
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastomaClaudia C Faria, Sameer Agnihotri, Stephen C Mack, et al.
Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.
Bulletin Du Cancer|January 26, 1999
[Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers]L Gautié, P Canal, A Menguy, et al.
JCO Precision Oncology|October 15, 2021
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an <i>NTRK2</i> Fusion: The Impact of Integrated Genomic ProfilingRoss Mangum, Jacquelyn Reuther, Kelsey C Bertrand, et al.
Nature|July 31, 2024
Histone serotonylation regulates ependymoma tumorigenesisHsiao-Chi Chen, Peihao He, Malcolm McDonald, et al.
Acta Neuropathologica Communications|September 3, 2024
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangementJulieann C Lee, Selene C Koo, Larissa V Furtado, et al.
Neuro-Oncology|May 29, 2023
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter studyAndrew M Donson, Kelsey C Bertrand, Kent A Riemondy, et al.
The Journal of Experimental Medicine|May 20, 2025
Correction: Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastomaStephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
The Journal of Experimental Medicine|April 6, 2019
Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastomaStephen C Mack, Irtisha Singh, Xiuxing Wang, et al.
Pageof 61